Recent financial disclosures indicate that Aarti Drugs reported consolidated total sales of approximately ₹702.78 crore with a net profit of ₹50.17 crore for the quarter ending June 2026. While year-on-year revenues displayed healthy double-digit expansion, quarterly sequential adjustments reflected ongoing margin sensitivities and competitive pricing dynamics within the global API marketplace.